BioSpace News Archive

Press Releases

Merck Animal Health to Acquire TARGAN

June 11, 2026
·
5 min read
Press Releases

Dr. Oladayo Oyelola Joins TrialAssure’s Advisory Board to Support Clinical Trial Transparency Strategy

Former Daiichi Sankyo transparency leader brings more than 30 years of experience across pharmaceutical research, clinical development, and global clinical trial disclosure

June 11, 2026
·
1 min read
Press Releases

Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026

June 11, 2026
·
16 min read
Press Releases

BlossomHill Therapeutics Presents Initial Clinical Data from Dose Escalation in Ongoing Phase 1/1b Trial of Novel Macrocyclic CLK Inhibitor, BH-30236, in Patients with R/R AML or HR-MDS at EHA 2026

June 11, 2026
·
5 min read
Press Releases

Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program

June 11, 2026
·
5 min read
Press Releases

Neion Bio Raises Oversubscribed $23 Million Series A to Advance Biologics Manufacturing Platform and Expand Pipeline

June 11, 2026
·
4 min read
Press Releases

C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population

June 11, 2026
·
10 min read
Press Releases

Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026

June 11, 2026
·
3 min read
Press Releases

Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026

June 11, 2026
·
8 min read
Press Releases

Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy

June 11, 2026
·
8 min read